Agilent Technologies, Inc. A
172.79
(0.05)
(0.03%)
as of 25 Sep
- Market cap
- $49.0B
- P/E
- 33.9×
Follow A
Indexes
indicate stock being part of an index,
Growth Flags
show if company had growth for consecutive years
Agilent Technologies, Inc. (A) Gross margin
Agilent Technologies, Inc.'s gross margin over the twelve months to 31 July 2026 was 53.8%, up 1.4 percentage points from fiscal 2025 (52.4%). Over the past ten years it has ranged from 50.5% (fiscal 2015) to 54.5% (fiscal 2018); the current reading is higher than 36% of that period. That is above the Diagnostics & Research industry median of 50.9% and in line with the Healthcare sector median of 53.7%.
Gross margin, annual
Annual
| Period | Gross margin | Change (points) |
|---|---|---|
| FY2025 | 52.4% | (1.87) |
| FY2024 | 54.3% | 3.59 |
| FY2023 | 50.7% | (3.64) |
| FY2022 | 54.4% | 0.43 |
| FY2021 | 53.9% | 0.78 |
| FY2020 | 53.1% | (1.19) |
| FY2019 | 54.3% | (0.21) |
| FY2018 | 54.5% | 0.90 |
| FY2017 | 53.6% | 1.36 |
| FY2016 | 52.3% | 1.74 |
Quarterly
| Period | Gross margin | Change (points) |
|---|---|---|
| Jul 2026 | 55.5% | 1.53 |
| Apr 2026 | 54.0% | 1.34 |
| Jan 2026 | 52.6% | (0.59) |
| Oct 2025 | 53.2% | 2.11 |
| 43 more quarters | Free account |
Against its own ten years
Low 50.5%
High 54.5%
Ten-year median
53.6%
Current reading's percentile
36
Gross margin against peers
| Company | Gross margin |
|---|---|
| ILMN Illumina, Inc. compare | 66.4% |
| NTRA Natera, Inc. compare | 65.2% |
| GH Guardant Health, Inc. compare | 65.0% |
| IDXX IDEXX Laboratories, Inc. compare | 62.5% |
| MTD Mettler-Toledo International, Inc. compare | 60.3% |
| A Agilent Technologies, Inc. | 53.8% |
| WAT Waters Corporation compare | 50.9% |
| DGX Quest Diagnostics Incorporated compare | 33.1% |
| IQV IQVIA Holdings Inc. compare | 33.0% |
| Diagnostics & Research industry median | 50.9% |
| Healthcare sector median | 53.7% |
| Market median | 46.3% |
What Gross margin is
Gross Margin tells an investor how much of each sale a company keeps after paying the direct costs of making or buying what it sells.
Gross Profit ÷ Revenue
More on A
- Revenue
- Net income
- EBITDA
- Free cash flow
- Operating cash flow
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- The full statement